HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Kiwamu Hanazono Selected Research
Kiwamu Hanazono Research Topics
Disease
5
Neoplasms (Cancer)
10/2021 - 05/2013
2
Respiratory Acidosis
05/2022 - 01/2019
2
Acidosis
05/2022 - 01/2019
2
Hypercapnia
05/2022 - 01/2019
2
Transitional Cell Carcinoma
10/2021 - 01/2015
1
Carcinoma (Carcinomatosis)
10/2021
1
Neoplasm Metastasis (Metastasis)
10/2021
1
Inflammation (Inflammations)
12/2019
1
Pancreatitis
10/2018
1
Body Weight (Weight, Body)
10/2018
1
Urinary Bladder Neoplasms (Bladder Cancer)
01/2015
1
Cystitis
01/2015
1
Melanoma (Melanoma, Malignant)
09/2013
1
Multiple Myeloma
01/2012
Drug/Important Bio-Agent (IBA)
4
Proteins (Proteins, Gene)
FDA Link
10/2021 - 01/2012
3
Messenger RNA (mRNA)
IBA
01/2015 - 05/2013
2
Doxorubicin (Adriamycin)
FDA Link
Generic
10/2013 - 09/2013
2
Carboplatin (JM8)
FDA Link
Generic
10/2013 - 09/2013
2
Vincristine (Oncovin)
FDA Link
Generic
10/2013 - 09/2013
2
Vinblastine (Vinblastine Sulfate)
FDA Link
10/2013 - 09/2013
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
10/2013 - 09/2013
2
Mitoxantrone (Novantrone)
FDA Link
Generic
10/2013 - 09/2013
2
Amino Acid Transport Systems (Amino Acid Transporter)
IBA
09/2013 - 05/2013
1
Contractile Proteins
IBA
05/2022
1
pimobendan
IBA
05/2022
1
Calcium
IBA
05/2022
1
Biomarkers (Surrogate Marker)
IBA
10/2021
1
Protein Isoforms (Isoforms)
IBA
10/2021
1
toceranib phosphate
IBA
07/2020
1
Cytokines
IBA
12/2019
1
Norepinephrine (Noradrenaline)
FDA Link
Generic
01/2019
1
Catecholamines
IBA
01/2019
1
Epinephrine (Adrenaline)
FDA Link
Generic
01/2019
1
Dobutamine
FDA Link
Generic
01/2019
1
Carbon Dioxide
IBA
01/2019
1
Colforsin
IBA
01/2019
1
Prednisolone (Predate)
FDA Link
Generic
10/2018
1
ErbB Receptors (EGF Receptor)
IBA
01/2015
1
Dacarbazine (DIC)
FDA Link
Generic
09/2013
1
Nimustine
IBA
09/2013
Therapy/Procedure
1
Anesthesia
05/2022
1
Positive-Pressure Respiration (Positive End-Expiratory Pressure)
05/2022
1
Aftercare (After-Treatment)
10/2018